Peptide Specialty Laboratories GmbH
Peptide Specialty Laboratories (PSL) GmbH was founded in September 2000 and is located in the Technology Park in Heidelberg, Germany. PSL is a spin-off laboratory of the German Cancer Research Center (DKFZ) in Heidelberg, where the co-founder and manager of the company, Dr. H.-R. Rackwitz, has gained a long time of experience in peptide syntheses and antibody preparation.
The main goal of PSL is based on the production of unmodified as well as modified peptides from mg to gram amounts and with lengths between 5 and 50 amino acids to a very high standard. PSL guarantees that peptides all are HPLC purified by preparative gradient purifications and analysed by mass spectrometry. PSL also offer syntheses of peptides with rare amino acids, unnatural amino acids, peptides with fluorescent moieties and biotinylated peptides. PSL's production facility has two peptide synthesizers which are able to synthesize each up to 48 peptides in parallel and three continuous flow synthesizers which allow syntheses of peptides with lengths of between 5 and 50 amino acids to a very high standard. A microwave assisted peptide synthesizer for the production of gram quantities of peptides is the latest addition to PSL's machinery and equipment. Furthermore, PSL produces bio-conjugates between peptides and proteins as well as column matrices and PSL are a main contributor of peptide specific antibodies for scientific and industrial research. PSL antibodies are primarily produced in guinea pigs or rabbits but immunisation of other animals is also available. Furthermore PSL specialize in the production of phosphospecific antibodies.
PSL customers are mainly found but not limited to the industry and research community of Germany and the European Community but also serve customers around the world.Contact
To learn more about Peptide Specialty Laboratories' services and capabilities and how they can assist your business, please contact Peptide Specialty Laboratories (PSL) directly.
- CRO, CMO, CRAMS & CDMO
- Drug Discovery